Invesco NASDAQ Biotech UCITS ETF (SBIO.L) — ETF Analysis on Winston
Key Facts
- Issuer: Invesco
- Category: Equity
- Asset Class: Equity
- Price: $76.39
- Expense Ratio: 40.00%
- Assets Under Management: $480M
- Inception Date: 2014-11-06
- Currency: GBP
Winston Score
Invesco NASDAQ Biotech UCITS ETF has a Winston Score of 65 out of 100.
Performance
- 1-Year Return: 57.41%
- 3-Year Return: 81.28%
- 5-Year Return: 41.49%
Top Holdings
VERTEX PHARMACEUTICALS ORD (N/A%), AMGEN ORD (N/A%), GILEAD SCIENCES ORD (N/A%), REGENERON PHARMACEUTICALS ORD (N/A%), ALNYLAM PHARMACEUTICALS ORD (N/A%)
Sector Breakdown
Healthcare (N/A%)